Accurate Diagnosis of the Invasion Depth in ESCC by a Deep Neural Network Analysis of NBI Endoscopy Data
NCT06252974 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2024-04-29
Summary
The goal of this observational study is to accurate diagnose the stage of esophageal squamous cell carcinoma in order to help physicians to decide the appropriate clinical treatment. The main question it aims to answer is:
• To get early accurate diagnosis of the invasion depth of esophageal squamous cell carcinoma by narrow-band imaging endoscopy data.
Participants' clinical informations from routine examinations and treatments will be collected, there will be no harm to participants.
Conditions
Sponsors & Collaborators
-
RenJi Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-25
- Primary Completion
- 2024-05-31
- Completion
- 2024-12-31
More Related Trials
-
Long-term Outcomes of Superficial Esophageal Squamous Cell Carcinoma
NCT02908204 ·Status: UNKNOWN
-
Diagnostic Value of Optical Enhancement Technology in Early Esophageal Squamous Neoplasia
NCT02851264 ·Status: UNKNOWN
-
The Role of Chromoendoscopy in the Early Detection of Esophageal Cancer in Patients With Prior Head and Neck Cancers
NCT02435602 ·Status: COMPLETED ·Phase: NA
-
China Early Esophageal Cancer Cohort
NCT06515964 ·Status: RECRUITING
-
Endoscopy Screening for Esophageal Cancer
NCT00927446 ·Status: TERMINATED
-
Exosome-based Liquid Biopsies for Upper Gastrointestinal Cancers Diagnosis
NCT06278064 ·Status: RECRUITING
-
Multimodal Functional Imaging Combined With Metabolomics in Predicting the Efficacy of nCRT for Locally Advanced ESCC
NCT04759235 ·Status: UNKNOWN
-
Submucosal Saline Injection Followed by Endoscopic Ultrasound
NCT06022978 ·Status: UNKNOWN ·Phase: NA
-
Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy
NCT06889402 ·Status: NOT_YET_RECRUITING
-
Precisely Estimation of the Prognostic Value of Lymph Node in ESCC
NCT04764240 ·Status: COMPLETED
-
Endoscopic Screening on Esophageal Cancer
NCT02094105 ·Status: COMPLETED ·Phase: NA
-
Prediction of Lymph Node Status in Stage T1 Esophageal Squamous Cell Carcinoma(RENMIN-237)
NCT05980403 ·Status: RECRUITING
-
The Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NEO-EC)
NCT06828718 ·Status: ACTIVE_NOT_RECRUITING
-
Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
NCT02665702 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of Full-field Coherence Tomography for ex Vivo Staging and Assessment of Superficial Esophageal Squamous Carcinoma: a Pilot Study
NCT03467529 ·Status: COMPLETED
-
Performance of White Light, NBI and Iodine Staining Endoscopy in the Diagnosis of Esophageal Lesions
NCT04170257 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Endoscopic Submucosal Tunnel Dissection for Superficial Esophageal Squamous Cell Carcinoma
NCT03404921 ·Status: COMPLETED ·Phase: NA
-
The PET-CT Predicting Response to Immunochemotherapy in Esophageal Cancer
NCT05615103 ·Status: UNKNOWN
-
A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients
NCT06960889 ·Status: ACTIVE_NOT_RECRUITING
-
The Efficacy of Immunodetection Point Inhibitors for Advanced Esophageal Cancer
NCT04074447 ·Status: UNKNOWN
-
Outcomes of A Novel Treatment Decision of Patients With Esophageal and Head and Neck Carcinoma Synchronously
NCT03450447 ·Status: UNKNOWN
-
Multimodal Deep Learning for Predicting Treatment Response to Neoadjuvant Chemoimmunotherapy in Esophageal Cancer
NCT07063901 ·Status: RECRUITING
-
Multi-institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell Carcinoma
NCT06241079 ·Status: COMPLETED
-
Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma
NCT07188103 ·Status: RECRUITING ·Phase: PHASE2
-
Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC
NCT06603402 ·Status: RECRUITING ·Phase: PHASE2